Compare Multitrend Indo Tbk (BABY) vs Ikapharmindo Putramas Tbk. (IKPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multitrend Indo Tbk vs Ikapharmindo Putramas Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp232 (market cap 776.51B, 45.12M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp199 (market cap 330.19B, 215.9K 24h volume). The key difference: Multitrend Indo Tbk is far larger — about 2.4× Ikapharmindo Putramas Tbk.'s market cap, and Multitrend Indo Tbk is more actively traded (45.12M versus 215.9K). Which is the better fit depends on your goals.
| BABY | IKPM | |
|---|---|---|
Market Cap | 776.51B | 330.19B |
Volume | 45.12M | 215.9K |
Lot | 451.21K | 2.16K |
Turnover | 11.77B | 42.44M |
Average Price | 260.94 | 196.56 |
Value | 11.77B | 42.44M |
Indicative Equilibrium Price | 232 | 199 |
Indicative Equilibrium Volume | 546 | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multitrend Indo Tbk
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Read more on BABY →About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →
